Physician profile
Rikee Fields
NPI 1134727530
$978.68
in general payments reported to CMS, 2019-2025
19 companies · $16.87 in 2025
The $16.87 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $380 · 2022: $107 · 2023: $181 · 2024: $294 · 2025: $16.87.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $492.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $491.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $178.94 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Boston Scientific Corporation | $156.42 | 2021 | |
| Lilly USA, LLC | $123.55 | 2021-2024 | Mounjaro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $70.78 | 2021-2023 | Jardiance |
| Novartis Pharmaceuticals Corporation | $65.86 | 2021-2024 | |
| Amgen INC. | $43.31 | 2021-2024 | Prolia, Evenity |
| Pfizer INC. | $41.58 | 2023-2024 | |
| Dexcom, INC. | $41.57 | 2021-2024 | Dexcom G6 Transmitter |
| Aimmune Therapeutics, INC. | $40.36 | 2024 | |
| Insulet Corporation | $35.41 | 2021-2022 | |
| Abbvie INC. | $35.17 | 2023 | |
| Almatica Pharma LLC | $24.02 | 2024 | Loreev Xr |
| Astrazeneca Pharmaceuticals Lp | $22.86 | 2024 | Airsupra |
| Phathom Pharmaceuticals, INC. | $20.11 | 2024 | Voquezna |
| Sanofi-Aventis U.S. LLC | $18.18 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $17.71 | 2022 | |
| Nestle Healthcare Nutrition INC. | $16.42 | 2021 | |
| Exact Sciences Corporation | $13.58 | 2024 | Cologuard Collection Kit |
| Mylan Specialty L.P. | $12.85 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rikee Fields listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.